Parschat, K.; Melsaether, C.; Jäpelt, K.R.; Jennewein, S.
Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth. Nutrients 2021, 13, 2871.
https://doi.org/10.3390/nu13082871
AMA Style
Parschat K, Melsaether C, Jäpelt KR, Jennewein S.
Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth. Nutrients. 2021; 13(8):2871.
https://doi.org/10.3390/nu13082871
Chicago/Turabian Style
Parschat, Katja, Cathrine Melsaether, Kristina Rasch Jäpelt, and Stefan Jennewein.
2021. "Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth" Nutrients 13, no. 8: 2871.
https://doi.org/10.3390/nu13082871
APA Style
Parschat, K., Melsaether, C., Jäpelt, K. R., & Jennewein, S.
(2021). Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth. Nutrients, 13(8), 2871.
https://doi.org/10.3390/nu13082871